Rufloxacin Hydrochloride | Interleukin Related interleukin-related.com

Product Name :
Rufloxacin Hydrochloride

Search keywords :
Rufloxacin hydrochloride

drugId :
null

Target Vo:
Topoisomerase IV

Target Vo Short Name :
Topoisomerase IV

Moa_Name:
Bacterial DNA gyrase inhibitors

First Approval Country :
Italy

First Approval Date Filter:
1992

Origin Company_Name :

Active Company_Name :
Hubei Sihuan Pharmaceutical Co Ltd

Active Indication_Name:
Bacterial Infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Intetumumab Epigenetics
CREB Rabbit mAb site
PP2A alpha + beta Antibody: PP2A alpha + beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to PP2A alpha + beta. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts